Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Cerence

GameStop

Coca-Cola

Monster Beverage

Pinterest

PayPal

Constellation Brands

The Monster Beverage-Constellation news and other market happenings.

Is a Monster Merger Brewing?

You would have been better off investing in the S&P 500.

If You Invested $100,000 in Canopy Growth When Canada Legalized Marijuana, This Is How Much You'd Have Right Now

Aurora Cannabis

Tilray Brands

U.S. legalization is still stalled, but Mexican marijuana legalization could be imminent.

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Dropped Today

Anheuser-Busch InBev

Molson Coors Brewing

Cannabis is a losing ball game – because you get into price wars where everyone loses. But the psychedelics industry has built-in competitive moats that differentiate it from pot.

The Reason I Was Wrong on Pot Stocks Is Why I'm Right About This

Canopy Growth vs. Aurora Cannabis: Which Company Had Better Earnings?

Cannabis Growth ETF

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Advisorshares Poseidon Dynamic Cannabis ETF

Trulieve Cannabis Corp.

AXS Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Timely, edifying episode with industry expert Brady Cobb. Recent cannabis legislation; moving from optics to real reform. SAFE Banking, uplisting and what it all means for cannabis investors.

Cannabis Stocks Are A Coiled Spring - Industry Update With Brady Cobb (Podcast)

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) has brought in the experts to assess the potential of the cannabinoid library licensed from the North American cannabis giant, Canopy Growth. It has access to 335 derivatives of the naturally occurring compounds found in cannabis plants.

Oxford Cannabinoid Technologies brings in a specialist R&D firm to help it unlock the potential of Canopy Growth library

Entegris

Greenlane Holdings

Intercure Ltd

Neptune Wellness Solutions Inc.

OrganiGram Holdings Inc.

Spotify

Teradyne

cbdMD Inc

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

It's Been a Blazing Hot Week for These 12 Cannabis Stocks

Canopy Growth Corp. CGC, -9.19% WEED, -9.32% on Friday named Judy Hong as interim chief financial officer and Tara Rozalowsky as interim chief product officer and launched an external search for both roles. Mike Lee, executive vice president and CFO and chief product officer Rade Kovacevic will depart the company on Dec. 31.

Canopy Growth names interim CFO and launches search for two key executives

Changes are designed to drive execution against the Company's strategic priorities SMITHS FALLS, ON, Nov. 19, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, today announced strategic changes to its Executive Management Committee. Effective immediately, Mike Lee, Executive Vice President and Chief Financial Officer, and Rade Kovacevic, President and Chief Product Officer will be stepping down from their respective roles on the Executive Management Committee and will depart from the company on December 31, 2021.

Canopy Growth Announces Changes to Executive Management Team

SNDL Inc.

HEXO Corp

Recent comments from would-be pot law reformers in the U.S. Congress aren't exactly heartening.

Why Canadian Pot Stocks, Like Sundial Growers, Are Falling Today

Cronos Group

An analyst initiated coverage on three of the stocks, but all of them fell as a result.

Why Canopy Growth, Cronos, Hexo, Sundial, and Tilray Stocks Are Plunging This Week

Barclays has issued a report that has cast doubt over an entire industry and has sent cannabis stocks plunging. Should you be worried?

Cannabis Stocks: How One Analyst Just Snuffed Out TLRY, CRON, CGC Stocks

Earlier this month, Canopy Growth Corporation (NASDAQ:CGC) (TSX:WEED) revealed a $CA16.3 million ($13.08 million) net loss in the second quarter of fiscal 2022 and a CA$77 million wider loss in EBITDA, versus the same period of last year. Moreover, the company pushed out a positive Adjusted EBITDA target due to market share challenges in the Canadian recreational business and a slower-than-expected ramp-up of US distribution for BioSteel, while revealing a 3% year-over-year decline in net revenue to CA$131 million.

Canopy Growth Is A 'Show-Me-Story' As It Posts Mixed Progress In KPIs, Analyst Argues

These three Canadian pot companies sport key features that should allow them to reward patient shareholders.

3 Risky Pot Stocks With Jaw-Dropping Growth Potential

Barclays analyst Guarav Jain on Thursday initiated coverage of three cannabis stocks but said their businesses are limited by the relatively small size of the legal market in Canada. Barclays launched overage of Tilray TLRY, -4.86% and Cronos CRON, -4.48% with an underweight rating and price targets of $10 and $5.50 respectively.

Barclays initiates coverage of Tilray, Cronos and Canopy Growth

Canadian Cannabis Stocks In November The post Are You Looking For Top Marijuana Stocks Right Now? 2 Pot Stocks To Watch appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are You Looking For Top Marijuana Stocks Right Now? 2 Pot Stocks To Watch

On Wednesday, Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) unveiled a new lineup of premium flower offerings across its 7ACRES, 7ACRES Craft Collective and DOJA brands, including a range of national and limited-edition craft strains. The Canadian cannabis giant noted that these strains have been meticulously cultivated to meet the growing demand of the Canadian flower market.

Canopy Growth's New Lineup Of Premium Cannabis To Meet Canada's Growing Demand

This pot company's Q2 earnings make you wonder whether it is time to give up hope on its rebound.

Should Investors Abandon Canopy Growth After Its Q2 Earnings?

It's looking like a "buy the rumor, sell the news" day in Cannabis-land.

Why Canopy and Sundial Dropped Today, but Curaleaf Popped

Carnival

Disney

Dollar Tree

Cyclical stocks in focus as cyclical market sentiment rises on China's October retail sales beat.

Top Cyclical Stocks To Invest In Now? 5 Names To Know

Heritage Cannabis Holdings Corp. (CSE:CANN) (OTCQX:HERTF) announced Monday that it has inked a commercial agreement with Canopy Growth Corp. (NASDAQ:CGC) for the supply of bulk concentrates, including live resin. Based in Toronto, the company recently provided the first shipment of live resin to the Canadian cannabis giant.

Heritage Cannabis: Will Supply Canopy Growth With Bulk Live Resin, Inks Commercial Deal, Completes First Shipment

Heritage Cannabis Holdings Corp said it has signed a commercial agreement with Canopy Growth Corp for the supply of bulk concentrates, including live resin. The company recently provided the first shipment of live resin to Canopy, with future purchase orders and shipments to follow.

Heritage Cannabis signs commercial agreement with Canopy Growth for the supply of bulk concentrates, including live resin

Producers have gotten into the habit of making incredibly aggressive forecasts.

1 Thing Canadian Cannabis Producers Should Stop Doing Right Now

Canopy Growth Corp. (NASDAQ:CGC) shares are trading higher Friday, possibly after Ohio's new Senate bill states that medical marijuana could be given to any patient who can be “reasonably expected to benefit” from it. The stock looks to be breaking out of a technical pattern and pushing higher.

Canopy Growth Breaks Past Resistance And Looks To Be Changing Trends

News for Canopy Growth Stock (CGC)